Nuclear medicine is an excellent networked educational program in the field of nuclear medicine aimed at training competitive specialists for Russian and foreign research and medical centers. TPU has developed this program in cooperation with leading research centers, medical educational institutions, science-intensive and high-tech enterprises in the field of medicine and medical physics in Russia. TPU has long-term experience in the development and production of medical radiopharmaceuticals using the basic facilities of the Tomsk Polytechnic University, such as the IRT-T research reactor and the R-7M cyclotron. The program divided into three terms covers basic physics of nuclear medicine and medical sciences, radiation safety, radiation therapy and imaging, and producing and application of radiopharmaceuticals.
Main modules
Anatomy and physiology. Bases of roentgenology
Clinical dosimetry
Treatment planning
Modern techniques of radiation therapy. Bases of radiation therapy planning
Clinical application of modern techniques of radioisotopic and roentgen diagnostics
Radiochemistry. Application of radionuclides and radiopharmaceuticals in diagnostics and therapy
Career Opportunities:
Positions and career fields:
· Researcher and medical physicist in the field of radiation therapy planning
· Researcher and medical physicist in the field of clinical dosimetry
· Radiological/Radiation safety officer
· Researcher and medical physicist in the field of imaging
· Teaching in the field of nuclear medicine
Types of organizations:
· Research institutes,
· medical centers and institutions,
· clinics,
· universities,
· medical laboratories
Internships:
· Tomsk regional oncology center
· Tomsk oncology research institute
· Tomsk cardiology research institute
· Kemerovo regional oncology center
Postgraduate Opportunities (Further Studies):
Post-graduate and post-doc programmes in the fields of research and development of clinical dosimetry techniques, planning radiation therapy, new methods for radiation therapy, producing new radiopharmaceuticals.